References: Based on STEP 1 (Wilding et al., NEJM 2021) and SURMOUNT-1 (Jastreboff et al., NEJM 2022) trials
[2][3] Because of its significant effect on growth and development as well as causing associated medical problems and reduced quality of life, childhood-onset GHD has been treated with replacement therapy for more than 30 years
The inflammatory response further drives the diseases by increasing oxidative stress, reducing the levels of growth factors, and increasing the release of pro-inflammatory cytokines by activated microglia and astrocytes (Lee et al., 2010
:
Aquesta reacci s catalitzada per un enzim acil-CoA gras sintetasa i portada a bon fi per un pirofosfat inorganic
Middle-aged women, in particular, experience metabolic changes related to hormonal shifts, menopause, and insulin sensitivity, which often coincide with weight gain that proves resistant to diet and exercise alone